Budget impact of adding lesinurad for second-line treatment of gout: a US health plan perspective
Klein, Robert W, Kabadi, Shaum, Cinfio, Frank N, Bly, Christopher A, Taylor, Douglas CA, Szymanski, Keith AVolume:
7
Language:
english
Journal:
Journal of Comparative Effectiveness Research
DOI:
10.2217/cer-2017-0103
Date:
August, 2018
File:
PDF, 1.15 MB
english, 2018